Public list Pharma Startups (6570):
Zurcara Therapeutics is developing a drug therapy to prevent hypoglycemia in people with diabetes. The Company's therapeutic is aimed at inhibiting a hormone in the pancreas called somatostatin, which does not function properly in diabetes.
Company (Alive / Active)
1300-661 University Avenue
Toronto, M5G 0B7
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)